Efficacy of SandostatinR LARR (long-acting somatostatin analogue) is similar in patients with untreated acromegaly and in those previously treated with surgery and/or radiotherapy-Reference-Cited by-同舟云学术

Efficacy of SandostatinR LARR (long-acting somatostatin analogue) is similar in patients with untreated acromegaly and in those previously treated with surgery and/or radiotherapy

Published:2004-03 Issue:3 Volume:60 Page:375-381
ISSN:0300-0664
Container-title:Clinical Endocrinology
language:en
Short-container-title:Clin Endocrinol

Author:

Ayuk John,Stewart Susan E.,Stewart Paul M.,Sheppard Michael C.,

Publisher

Wiley

Subject

Endocrinology, Diabetes and Metabolism,Endocrinology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1365-2265.2004.01992.x/fullpdf

Reference15 articles.

1. Outcome of transphenoidal surgery for acromegaly and its relationship to surgical experience

2. Long-Term Safety and Efficacy of Depot Long-Acting Somatostatin Analogs for the Treatment of Acromegaly

3. Two-Year Follow-Up of Acromegalic Patients Treated with Slow Release Lanreotide (30 mg)

4. Primary Medical Therapy for Acromegaly: An Open, Prospective, Multicenter Study of the Effects of Subcutaneous and Intramuscular Slow-Release Octreotide on Growth Hormone, Insulin-Like Growth Factor-I, and Tumor Size

Cited by 59 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Craniopharyngioma and Other Sellar Tumors;Pediatric Neurosurgery for Clinicians;2022

2. Somatostatin analogs, cabergoline and pegvisomant: comparing the efficacy of medical treatment for acromegaly;Expert Review of Endocrinology & Metabolism;2016-09-07

3. Monotherapy with lanreotide depot for acromegaly: long-term clinical experience in a pituitary center;Pituitary;2016-05-07

4. Pasireotide for treating acromegaly;Expert Opinion on Orphan Drugs;2016-04-12

5. Interpreting biochemical control response rates with first-generation somatostatin analogues in acromegaly;Pituitary;2015-10-30